biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by greaterfoolFredon Mar 18, 2020 8:08pm

65 Views

Post# 30824195

RE:RE:RE:Priorities

We're not giving thumbs up to 20% unemployment fats, we're giving thumbs up to a poster who keeps posting things to read, most of which are relevant, and who suffers abuse from guys like you with very little complaint. It's not like the bullboard is overrun with posts; most of us don't find it that hard to keep up.

Bullboard Posts

Unique Battery Metals opportunity in Quebec